Targeting MEK for the treatment of non-small-cell lung cancer

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S377-8. doi: 10.1097/JTO.0b013e31826df0bc.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / metabolism
  • Clinical Trials as Topic
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / metabolism
  • MAP Kinase Kinase 1 / antagonists & inhibitors*
  • MAP Kinase Kinase 1 / metabolism
  • Molecular Targeted Therapy*

Substances

  • Antineoplastic Agents
  • MAP Kinase Kinase 1
  • MAP2K1 protein, human